HansBiomed Corporation (KOSDAQ:042520)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,100
-460 (-3.66%)
At close: Nov 16, 2026

HansBiomed Revenue

HansBiomed had revenue of 36.35B KRW in the quarter ending June 30, 2026, with 64.95% growth. This brings the company's total for the last twelve months to 124.81B, up 45.85% year-over-year. In the fiscal year ending September 30, 2025, HansBiomed had annual revenue of 89.78B with 10.65% growth. That makes HansBiomed the 23,218th largest company in the world by revenue and 1,311th in South Korea.

Revenue (ttm)
124.81B
Revenue Growth
+45.85%
P/S Ratio
1.38
Revenue / Employee
396.23M
Employees
315
Market Cap
172.56B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Human Tissue Section 73.78B 57.4%
  • Medical Device Division 46.92B 36.5%
  • Other Section 7.76B 6.0%

By Geography

Chart
  • South Korea 57.85B 64.4%
  • North America 14.56B 16.2%
  • Asia 12.05B 13.4%
  • Other 2.18B 2.4%
  • South America 1.87B 2.1%
  • Europe 1.28B 1.4%
Fiscal year ended Sep 30, 2025 See the full HansBiomed breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202589.78B8.64B10.65%
Sep 30, 202481.14B3.11B3.98%
Sep 30, 202378.03B3.57B4.80%
Sep 30, 202274.46B15.36B25.99%
Sep 30, 202159.10B-21.00B-26.22%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
ISU Abxis51.04B
Genome & Company24.46B
NIBEC22.60B
Bio Solution17.39B
S.Biomedics16.49B
curacle co.,ltd.8.24B
IntoCell3.19B
Y-Biologics3.17B
Revenue Rankings